The analysis of more than
3,000 proteins
whose objective is to determine their relationship with
SARS-CoV-
2 and, consequently, identify which subgroups may be linked to the
development of severe covid-19
, has once again suggested the role of the different blood groups in the origin of the most serious forms of the disease, as revealed by some studies focused on this aspect at the beginning of the pandemic.
This is the first study to evaluate
such a large number
of proteins and whose data, published by PLOS Genetics, open up new perspectives in the
prevention and treatment
of severe covid-19.
According to
Gerome Breen
, Professor of Genetics at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King's College London, and a co-author of the article, "out of thousands of blood proteins, we have
narrowed the list down to about 14
that have some kind of relationship causal with the
risk of suffering from severe forms
of the disease. In addition to being a way to continue investigating and understanding the mechanisms of covid-19, the
challenge
is to develop
new treatments
, as well as
preventive strategies
".
Higher and lower risk
The study, funded in part by the Maudsley Biomedical Research Center of the National Institute for Health Research (NIHR), in the United Kingdom, has used a
genetic tool to analyze more than 3,000 proteins
.
Of the total, 6 have been identified
that could be associated with a higher risk
of severe covid-19 and
8 that, on the contrary, could play a protective role
.
The protein
called ABO
, for which a causal connection has been observed
with the risk of developing covid-19
, determines blood groups in humans, which "suggests that
blood groups
play a decisive role in people developing
forms of the disease
", indicates
Alish Palmos
, of the IoPPN.
"Focusing on this group of proteins is a critical first step in
discovering targets
for developing new treatments."
Study co-author Vincent Millischer
, a professor at the Medical University of Vienna in Austria, explains that in the study, the groups were defined by their
genetic propensity
for different blood protein levels, which "allows us to assess the causal direction between
elevated blood protein levels
and the
severity
of covid-19, while avoiding the influence of environmental effects."
Severity due to covid-19 in this study was defined by
hospitalization
, on the one hand, and
respiratory assistance or death
.
The
ABO protein
was causally associated with both a
higher risk of hospitalization
and the
need for respiratory assistance
, a fact that supports previous studies on blood group and a
higher probability of death
from this viral disease.
For example, among the different works published in this regard, a
2021
investigation in Blood Advances, endorsed by the American Society of Hematology, concluded that people with
group 0 blood
were
less likely to develop severe symptoms of covid-19
when infect.
He also observed a lower prevalence of
heart disease
and
thrombosis
in relation to those infected with group A, B or AB6.
Following the line of this previous research, scientists have observed that the
proportion of group A
is higher in individuals positive for covid-19.
Group A, candidate for follow-up
"Precise blood type is not associated with risk of severe COVID-19, but since
previous analyzes
have found that the proportion of type
A people
is higher in COVID-19 positive individuals, we think blood type A is the most likely candidate for
follow-up studies,
" says
Christopher Hübel
of IoPPN.
In his opinion, the enzyme
helps determine the blood group
of an individual.
"The data links it to both the risk of hospitalization and the need for respiratory support or death."
Research has also identified
3 adhesion molecules
, associated with a
lower risk of hospitalization
and
respiratory support
.
Conforms to The Trust Project criteria
Know more
covid 19
Coronavirus
Austria
United Kingdom
London
Psychology
Covid-19 Four communities are already below the threshold of 500 cases: Andalusia, Melilla, Madrid and Castilla-La Mancha
The IdeasMark Woolhouse: "People accepted confinements with false expectations"
HealthThe EMA approves the Moderna vaccine for children between 6 and 11 years old
See links of interest
Last News
best colleges
Topics
Work calendar 2022
Seville - West Ham United
Asvel Villeurbanne - Bitci Baskonia
Real Madrid - Olympia Milan
Barcelona - Galatasaray